| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.08 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.08 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |